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repair: A statewide experience
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Melinda A. Maggard, MD, MSHS, Michelle Agustin, MPH, Peter F. Lawrence, MD,
and Clifford Y. Ko, MD, MS, MSHS, Los Angeles, California
Objective: The purpose of this study was to determine the in-hospital, 30-day, and 365-day mortality for the open repair
of abdominal aortic aneurysms (AAAs), when stratified by age, in the general population. Age stratification could provide
clinicians with information more applicable to an individual patient than overall mortality figures.
Methods: In a retrospective analysis, data were obtained from the California Office of Statewide Health Planning and
Development (OSHPD) for the years 1995 to 1999. Out-of-hospital mortality was determined via linkage to the state
death registry. All patients undergoing AAA repair as coded by International Classification of Diseases, 9th Revision
(ICD-9) procedure code 38.44 and diagnosis codes 441.4 (intact) and 441.3/441.5 (ruptured) in California were
identified. Patients <50 years of age were excluded. We determined in-hospital, 30-day, and 365-day mortality, and
stratified our findings by patient age. Multivariate logistic regression was used to determine predictors of mortality in the
intact and ruptured AAA cohorts.
Results:We identified 12,406 patients (9,778 intact, 2,628 ruptured). Mean patient age was 72.4 7.2 years (intact) and
73.9  8.2 (ruptured). Men comprised 80.9% of patients, and 90.8% of patients were white. Overall, intact AAA patient
mortality was 3.8% in-hospital, 4% at 30 days, and 8.5% at 365 days. There was a steep increase in mortality with
increasing age, such that 365-day mortality increased from 2.9% for patients 51 to 60 years old to 15% for patients 81 to
90 years old. Mortality from day 31 to 365 was greater than both in-hospital and 30-day mortality for all but the
youngest intact AAA patients. Perioperative (in-hospital and 30-day) mortality for ruptured cases was 45%, andmortality
at 1 year was 54%.
Conclusions: There is continued mortality after the open repair of AAAs during postoperative days 31 to 365 that, for
many patients, is greater than the perioperative death rate. This mortality increases dramatically with age for both intact
and ruptured AAA repair. ( J Vasc Surg 2006;43:224-9.)Abdominal aortic aneurysm (AAA) repair is a proce-
dure performed primarily to prolong life by preventing
eventual aneurysm rupture. As such, the mortality associ-
ated with the operation is of prime consideration. Tradi-
tional 30-day postoperative reporting suggests that mortal-
ity is 2% to 6.5% in institutional and trial-based studies.
Figures of 8% are reported in administrative database
reviews of more generalized segments of the population.1,2
These figures can aid the clinician in planning and inform-
ing patients about the risks of surgery, but the ranges of
mortality reported in the literature are too broad in most
cases to be accurately applied to an individual patient.
We have recently become interested not only in the
30-day mortality after vascular interventions but also in the
mortality over the balance of the postoperative year. For
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224carotid endarterectomy and thoracoabdominal aneurysm
repair, we have demonstrated continued and significant
mortality throughout this time interval.3,4 Although ad-
vancing age clearly predisposed the patients in these studies
to higher mortality at both time points, the literature shows
that even patients at the extremes of age can undergo
surgical procedures safely with proper selection.5,6 It is
important to understand and appreciate, however, the sur-
vival of such patients beyond the initial 30-day period may
be significantly compromised.
We hypothesized that there would be continued mor-
tality throughout the remainder of the first postoperative
year for patients undergoing open repair of AAA in the
general population. In addition, we hypothesized that
stratifying results by age would demonstrate increasing
perioperative and 365-day mortality.
METHODS
Data source. Discharge data for 1995 to 1999 were
obtained from the California Office of Statewide Health
Planning and Development (OSHPD). The OSHPD data-
base is compiled annually and includes discharge abstracts
from all licensed nonfederal hospitals throughout Califor-
nia. Each discharge record includes the patient’s age, gen-
der, race/ethnicity, insurance status, admitting hospital,
and source of admission (emergency department vs other;
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per hospitalization) and procedures (up to 20 per hospital-
ization) are also provided. All procedures and diagnoses are
categorized by the International Classification of Disease,
9th Clinical Modification (ICD-9) coding scheme. In Cal-
ifornia, the OSHPD data are linked to the state death
certificate file for individual patients, allowing longitudinal
follow-up of inpatients after their discharge from the
hospital.7
Data analysis. All patients undergoing AAA repair
(ICD-9 procedure code 38.44 and diagnosis codes 441.4
for intact and 441.3/441.5 for ruptured) in California at
nonfederal institutions between 1995 and 1999 were iden-
tified. Patients who were not California residents were
identified by ZIP code and county of residence and excluded
because of the inability to track them after discharge.
The demographic data listed above, as well as Charlson
index8 and annual hospital volume for AAA repair (top
20%, middle 40%, and lowest 40% of total cases performed)
were obtained. The Charlson Comorbidity Index, a weighted
sum score used to risk-adjust patients, is determined by the
presence and severity of 19 conditions, including myocar-
dial infarction, congestive heart failure, diabetes mellitus,
and renal disease.
The OSHPD data set provides data on whether the
admission is elective (planned 24 hours in advance) or
unscheduled. For our cohorts, intact AAA patients were
those with a diagnosis of intact AAA and a planned admis-
sion, and ruptured AAA patients were those with a diagno-
sis of ruptured AAA regardless of admission status. Patients
with intact aneurysms but unscheduled admission status
were excluded (846 patients) owing to the relatively small
size of the group and presumed heterogeneity of these
cases.
The inpatient file is linked to the state death certificate
file, allowing us to determine mortality rates at 30 and 365
days for the patients who underwent AAA repair. Mortality
rates were stratified by patient age and intact vs ruptured
diagnosis. The mortality rates for AAA patients were also
compared with age-matched data from the general popu-
lation obtained from the National Vital Statistics report of
2002.9
It is important to note that for in-hospital and 30-day
mortality, these variables are not linked and thus will not
have 100% agreement. Patients dying without hospital
discharge but 30 days will not be counted as 30-day
deaths, and patients dying after discharge but 30 days
have elapsed since operation are only counted as deaths
within 30 days.
We performed multivariate logistic regression analysis
to determine predictors of mortality at three time periods
after surgery: 0 to 30 days, 31 to 365 days, and 0 to 365
days, with the independent variables of age, Charlson Co-
morbidity Index, race, gender, and hospital volume. For
the regression model predicting day 31 to 365 mortality,
patients who died on days 0 to 30 were excluded. Statistical
analyses were performed with SAS version 8.01 (SAS Insti-tute, Cary, NC) and Stata 8.0 (Stata Corp, College Station,
Texas). Values of P  .05 were considered significant.
RESULTS
A total of 12,406 patients underwent AAA repair in
California nonfederal hospitals from 1995 to 1999. The
average age was 72.4 (intact) and 73.9 years (ruptured) at
the time of procedure; 78.8% of the AAA repairs were
performed for intact aneurysms and the balance for rup-
tured cases. Overall, 90.8% of the patients were white, with
no other groups represented by 8.1% of the study popu-
lation, and 81% were men. Nineteen percent of patients
were admitted to high-volume (32.5 cases/year), 41.6%
to medium-volume (16 to 32.5 cases/year), and 39.4% to
low-volume hospitals (16 cases/year). Comparison of
the demographic data with respect to intact vs ruptured
AAAs are summarized in Table I.
For patients with intact AAAs, mortality was 3.8%
in-hospital, 4% at 30 days, and 8.5% at 1 year. Mortality
results were also stratified by age in decade as listed in Table
II. Percentages shown in the table represent mortality using
the total number of patients undergoing operation for each
group. For example, the 8.4% mortality for ruptured AAA
repair at the 31-day to 365-day time interval represents 220
deaths out of the initial 2,628 patients. This number in-
creases to 15.3% if only patients surviving the initial 30 days
are considered (220 deaths out of 1,442 patients). For all
patients with intact AAAs 59 years old, the mortality for
the balance of the postoperative year was greater than that
in the perioperative period. This 31- to 365-day mortality
was higher than that for age-matched population data from
the National Vital Statistics Report9 (Fig 1).
For ruptured cases, mortality was 45.7% in-hospital,
Table I. Demographics of all patients (n  12,406)
undergoing abdominal aortic aneurysm repair from 1995
to 1999 by ruptured or intact status
Variable
Intact
(n  9778)*
Ruptured
(n  2628)*
Age (years) 72.4  7.2 73.9  8.2
Charlson Comorbidity Index 2.1  1.3 2.4  1.5
Race
White 91.40 88.60
Black 2.40 3.30
Other 6.20 8.10
Sex
Male 80.90 80.90
Female 19.10 19.10
Insurance
Medicare 74.00 71.30
Medicaid 1.50 2.70
Private 23.30 23.60
Other 1.20 2.40
Hospital volume
High (top 20%) 20.90 12.60
Medium (mid 40%) 44.20 33.50
Low (bottom 40%) 34.90 53.90
*Data are mean  standard deviation and (%).45.1% at 30 days, and 53.5% at 1 year. Thirty-day mortality
g ope
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mortality between days 31 and 365 was also substantial.
One-year mortality was 35.4% for patients 51 to 60 years
old and 70% for patients 80 years old (Table II). A
comparison of 365-day mortality between AAA patients
and age-matched population data from the National Vital
Fig 1. Mortality during postoperative days 31 to 365 for patients
undergoing elective and ruptured abdominal aortic aneurysm
(AAA) repair is shown vs 11 months of age-matched mortality for
white men in the United States. The 30-day perioperative mortal-
ity is subtracted from the comparison.
Fig 2. Overall 365-day mortality is displayed for both elective
and nonelective abdominal aortic aneurysm (AAA) repair, again vs
mortality of age-matched population controls for a 1-year period.
Table II. Mortality rates stratified by age for abdominal a
Intact
Overall
n  9778 (%)
51-60 yrs
n  593 (%)
In-hospital 3.80 1.50
30-day 4.00 1.70
31-365* 4.50 1.20
365-day 8.50 2.90
Ruptured
Overall
n  2628 (%)
51-60 yrs
n  158 (%)
6
n 
In-hospital 45.70 29.80
30-day 45.10 28.50
31-365 day* 8.40 6.90
365-day 53.50 35.40
*The denominator for this cohort is the total number of patients undergoinStatistics Report is shown in Fig 2.Multivariate logistic analysis was performed for predic-
tors of 30-day, day 31 to 365, and 1-year mortality. For all
patients, advancing age and Charlson Comorbidity Index
were independent risk factors for mortality at all time
points, while controlling for the other independent vari-
ables included in the regression model. Female gender was
associated with increased odds of mortality for all but
patients with intact AAA repairs at the 31- to 365-day
interval. Black race was associated with increased odds of
late mortality for intact AAA operations (31 to 365 days
and 1 year), and for patients with a ruptured AAA, the
association was decreased odds of mortality at 0 to 30 days
and 1 year. Volume analysis demonstrated a mortality asso-
ciation with low-volume hospitals for patients with both
intact and ruptured AAA at the 30-day and 1-year time
periods. These data, as well as associations of mortality with
insurance status, are summarized in Tables III, IV, and V.
DISCUSSION
In this study, we report the 365-day mortality for open
AAA repair in a large group of patients (12,406) from the
general population. As we hypothesized, there is continued
mortality for these patients beyond the initial 30-day period
above what would be anticipated in the general population.
In addition, mortality at all time points increases with
patient age. The linkage of OSHPD to the state death files
allows these observations to be made and adds a new
dimension to studies that used large administrative data-
bases. Because AAA repair is performed to prolong life,
1-year mortality should be an important consideration
when contemplating this operation.
Our results for elective AAA repair demonstrate mor-
tality rates of 3.8% for the in-hospital interval and 4.5% at
30 days. Mortality in single-institution reviews tends to be
lower, from 0% to 1.2%.10,11 This contrasts with 8.4%
inpatient mortality using the National Hospital Discharge
data12 and 4.2% using the Nationwide Inpatient Sample
(NIS).13 These differences may represent volume-outcome
discrepancies, as a report has shown twice the mortality for
aneurysm repair
yrs
050
71-80 yrs
n  4935
81-90 yrs
n  1181
91-100 yrs
n  19
0 4.40 6.10 5.30
0 4.40 7.10 10.50
0 5.10 7.60 15.80
0 9.50 14.70 26.30
yrs
(%)
71-80 yrs
n  1178 (%)
81-90 yrs
n  514 (%)
91-100 yrs
n  59 (%)
47.50 58.00 74.60
46.90 58.20 79.70
8.60 12 5.10
55.50 70.20 84.80
ration for each age group.ortic
61-70
n  3
2.4
2.6
2.7
5.3
1-70
719
34.90
33.80
5.80
39.60surgeons who perform fewer than four AAA repairs a year vs
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64 AAA studies demonstrates an overall mortality of 5.5%
at 30 days.15
Few studies address 365-day mortality, with rates of 6%
to 10.8% for intact AAA repair and 45.9% to 53% for
ruptured AAA.8,16,17 Our overall 1-year mortality data for
intact (8.5%) and ruptured (53.5%) AAAs are close to these
figures; however, it is revealing to note the large range in
these numbers when stratified by age. A number of 10% is
clearly unrealistic for both the 55-year-old patient (365-day
mortality of 2.9%) and the 85-year-old (365-day mortality
Table III. Multivariate logistic regression model predictin
30-day mortality
Intact (n  9
OR
Age (years) 1.06*
Female 1.56*
Charlson Comorbidity 1.41*
Index
Race
White 1
Black 1.22
Other race 1.01
Insurance
Medicare 1
Medicaid 1.64
Private 1.08
Other 2.91*
Annual hospital volume
High 1
Middle 1.42*
Low 1.71*
OR, odds ratio; CI, confidence interval.
*P  .05.
Table IV. Multivariate logistic regression model predictin
31- to 365-day mortality
Intact (n 
OR
Age (years) 1.07†
Female 1.04
Charlson Comorbidity Index 1.42†
Race
White 1
Black 1.91†
Other Race 1.09
Insurance
Medicare 1
Medicaid 1.5
Private 0.89
Other 1
Annual hospital volume
High 1
Middle 0.92
Low 1.08
OR, Odds ratio; CI, confidence interval.
*Please note, the samples sizes do not include patients with mortality durin
†P  .05.of 14.7%).Several studies have reported volume-based outcomes
after AAA, with more favorable results at higher-volume
centers.18,19 Our data are in agreement with these findings,
since low-volume hospitals demonstrate increased odds of
both 30-day and 365-day mortality for intact and ruptured
AAA. In addition, increasing age and Charlson score are, as
expected, predictors of increasedmortality at all time points
and for both intact and ruptured cases.
This current review has several limitations. One prob-
lem in evaluating the mortality for AAA repair via adminis-
trative databases is the lack of data regarding aneurysm size.
-day mortality
Ruptured (n2628)
5% CI OR 95% CI
4, 1.08) 1.06* (1.05, 1.07)
3, 1.97) 1.33* (1.08, 1.63)
3, 1.49) 1.07* (1.01, 1.13)
— 1 —
4, 2.34) 0.50* (0.31, 0.80)
6, 1.55) 0.88 (0.66, 1.19)
— 1 —
4, 3.61) 1.83* (1.09, 3.07)
1, 1.44) 1.30* (1.07, 1.59)
7, 6.16) 1.74* (1.02, 2.98)
— 1 —
5, 1.92) 1.07 (0.82, 1.39)
6, 2.32) 1.54* (1.20, 1.98)
- to 365-day mortality*
8) Ruptured (n  1442)
95% CI OR 95% CI
1.05, 1.09) 1.07† (1.05, 1.09)
0.81, 1.33) 1.49† (1.02, 2.17)
1.35, 1.50) 1.52† (1.37, 1.68)
— 1 —
1.11, 3.30) 0.62 (0.27, 1.47)
0.73, 1.64) 1.19 (0.71, 1.99)
— 1 —
0.68, 3.30) 1.08 (0.35, 3.31)
0.67, 1.18) 1.36 (0.94, 1.99)
0.31, 3.20) 2.18 (0.78, 6.09)
— 1 —
0.71, 1.20) 1.2 (0.73, 1.97)
0.83, 1.40) 1.25 (0.78, 2.00)
first 30 days.g 30
778)
9
(1.0
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g theIn addition, there is also the issue of selecting out for less
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simplest operations.10 This issue was addressed in studies
that showed AAA data remained unchanged when codes
were used for more complex disease.20,21
Mention should also be made regarding the absence of
endovascular aneurysm repair (EVAR) data in this report.
Given the study years, it is unlikely that our population
contained a significant number of EVAR cases. Advantages
have now been shown in terms of quality-of-life parame-
ters, recovery time, and length of hospitalization for
EVAR.22-24Decreased perioperative mortality vs open re-
pair has been reported, but this is not a consistent find-
ing.14,25,,26 It is interesting to note that the 1-year mortal-
ity in the Guidant trial was 6%.27 This is the same number
found in The Cleveland Clinic’s study of open cases at 365
days.8 More recent data show no long-time survival benefit
for endovascular vs open repair.28,29 All of these reports
represent the experiences of specialized centers, and this un-
derscores the importance of establishing the age-stratified
mortality for EVAR in the general population.
Finally, our data are predominantly drawn from a white
male population. Although these data are consistent with
prior administrative database analyses of patients undergo-
ing AAA repair and other vascular procedures, the findings
may have limited application to other patients.30,31 Our
regression analysis does allow for an examination of gender
and race, but where no association with mortality was
identified, the small numbers of women and minorities in
the current cohort may play a role. Further study with
minority and female patients is warranted.
CONCLUSIONS
Our study demonstrates the continued mortality after
open repair of both intact and ruptured AAAs. Age strati-
Table V. Multivariate logistic regression model predicting
365-day mortality
Intact (n  9
OR
Age (years) 1.07*
Female 1.28*
Charlson Comorbidity 1.48*
Index
Race
White 1
Black 1.60*
Other Race 1.05
Insurance
Medicare 1
Medicaid 1.58
Private 0.98
Other 1.92
Annual hospital volume
High 1
Middle 1.1
Low 1.31*
OR, Odds ratio; CI, confidence interval.
*P  .05fication gives a more accurate view of mortality at both the30 and 365-day time points for a particular patient, infor-
mation that is potentially very helpful in clinical decision-
making. A more meaningful patient provider discussion is
likely when these focused data are used, so that an 85-year-
old and his or her physician can consider 15% mortality
rather than the 3% mortality more appropriate for a patient
in their 50s. It should also be remembered that we are only
presenting data on mortality, and there can also be serious
morbidity associated with AAA repair.
This study raises the question of what is causing the
mortality, particularly since it is significantly higher than
that of the background general population. It may repre-
sent delayed or lingering complications, the role of aneu-
rysmal disease as a marker of early mortality, or even the
role of the postsurgical inflammatory response in decreased
life expectancy.32 This may offer an opportunity for risk
reduction in the postsurgical patient and is an area deserv-
ing of increased investigation.
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